UCLA, 뇌 손상 복구를 위한 첫 뇌졸중 재활 약물 발견 (2025)

This discovery marks a pivotal shift from physical rehabilitation to molecular medicine in stroke recovery, addressing the limitations of high-intensity therapy through pharmacological intervention. By targeting specific neural circuits to restore gamma oscillations, DDL-920 represents a significant advancement in neuroplasticity research that could fundamentally transform long-term disability management.